Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gossamer Bio (GOSS) Net Margin (2022 - 2025)

Historic Net Margin for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to 362.73%.

  • Gossamer Bio's Net Margin fell 378000.0% to 362.73% in Q3 2025 from the same period last year, while for Sep 2025 it was 791.95%, marking a year-over-year decrease of 7212400.0%. This contributed to the annual value of 62.32% for FY2024, which is N/A changed from last year.
  • Latest data reveals that Gossamer Bio reported Net Margin of 362.73% as of Q3 2025, which was down 378000.0% from 333.13% recorded in Q2 2025.
  • In the past 5 years, Gossamer Bio's Net Margin ranged from a high of 1698.73% in Q3 2022 and a low of 397.03% during Q1 2025
  • Over the past 4 years, Gossamer Bio's median Net Margin value was 225.89% (recorded in 2024), while the average stood at 633.3%.
  • Examining YoY changes over the last 5 years, Gossamer Bio's Net Margin showed a top increase of -378000bps in 2025 and a maximum decrease of -3845000bps in 2025.
  • Over the past 4 years, Gossamer Bio's Net Margin (Quarter) stood at 1655.19% in 2022, then fell by -12bps to 1453.0% in 2023, then tumbled by -84bps to 225.89% in 2024, then plummeted by -261bps to 362.73% in 2025.
  • Its Net Margin stands at 362.73% for Q3 2025, versus 333.13% for Q2 2025 and 397.03% for Q1 2025.